Sinntaxis
Lund, SE · 1 known investors
Sinntaxis is a pharmaceutical company developing mGluR5 negative allosteric modulators as a drug therapy to restore brain function and support recovery after stroke and brain injury. Spun out of Lund University, it runs a preclinical discovery platform for stroke recovery research and licensed IP on this treatment approach.
BiotechDeep TechHealthtech
Founders & leadership
TW
Tadeusz WielochFounder & CEO
Investors · 1
Frequently asked questions
- What does Sinntaxis do?
- Sinntaxis is a pharmaceutical company developing mGluR5 negative allosteric modulators as a drug therapy to restore brain function and support recovery after stroke and brain injury. Spun out of Lund University, it runs a preclinical discovery platform for stroke recovery research and licensed IP on this treatment approach.
- Who founded Sinntaxis?
- Sinntaxis was founded by Tadeusz Wieloch.
- Who are Sinntaxis's investors?
- Sinntaxis's investors include LU Innovation.
- Where is Sinntaxis headquartered?
- Sinntaxis is headquartered in Lund, SE.